HPV Vaccines: A Danish DocumentaryBy Norma Erickson All three girls have been examined from head to toe with no conclusive diagnosis and no help with their symptoms, much like the girls in other countries where HPV vaccines are being used. During the documentary, two Danish doctors from Frederiksberg Hospital said they have never seen anything similar to this during their entire careers. Both doctors said they had sent correspondence to the Danish Health and Medicines Authority a total of four times during the last year to warn them of possible adverse events after HPV injections. Dr. Louise Brinth of Frederiksberg Hospital has personally examined around 80 girls whom she suspects may be suffering adverse effects of HPV vaccinations. She states: Danish Director of Health, Henrik G. Jenson agrees but stated: While conducting research prior to the production of this documentary, TV2 requested the Danish Health and Medicines Authority to provide full disclosure of all documents pertinent to the HPV vaccination program in Denmark. Unfortunately, Director Henrik G. Jenson and his staff forgot to supply the news team with any information regarding the four warnings the Danish Health and Medicines Authority had received from medical professionals in their country. Watch the Danish Documentary with English subtitles here: This HPV vaccine documentary made a huge impact A closed Facebook page set up for suspected victims of adverse reactions to Gardasil in Denmark reported having 398 members before this documentary was aired. A short two weeks later membership had increased to 938. Because each request for membership is contacted personally by the administrators of the group for verification, there are an additional 40 people currently waiting to be granted membership. Much to the credit of the Danish health authorities, they are making efforts to respond in an appropriate manner to the crisis they are facing in the wake of their HPV vaccination program. Denmark is divided into five healthcare regions. They have established a single point of entrance in each one of these regions to accept and examine anyone suspected of having a negative reaction to Gardasil. So far there is no official protocol established for the analysis and treatment of those admitted. Danish health authorities realize that the side effects are extremely serious and want to do more research. Unfortunately, it will take months (if not years) of research to discover exactly what has happened to these girls much less develop successful protocols to treat them without cooperation on a global scale. Where does this leave the survivors in the meantime? Should the HPV vaccination program be halted until this research is completed? Are those in charge of the Danish Health and Medicines Authority willing to risk the 2500 serious adverse reactions per 100,000 Gardasil recipients disclosed in Mercks latest prescribing information packet to try and avoid 12.1 cases of cervical cancer per 100,000? Are the women of Denmark willing to accept the same risk? Do the women of Denmark think it is reasonable to trade 2500 potentially devastating medical conditions to save 12 people per 100,000 users from the diagnosis of a very treatable cancer? As a matter of fact, Gardasil was introduced in Denmark in 2009. In 2008, the youngest woman to die of cervical cancer in Denmark was 30 years old. Three years after the introduction of Gardasil (in 2012), the youngest woman to die of cervical cancer was only 20. Why is this? Consider this chart from Denmark: One of the studies Merck presented to the FDA prior to marketing approval indicated that those who had been previously exposed to vaccine-relevant HPV types prior to vaccination may have a 44.6% greater chance of being diagnosed with pre-cancerous lesions. Could the increased rate of cervical cancer deaths be an indication this study was correct? The Danish health authorities and political representatives need to understand their experience with Gardasil is not unique to their country. Every country using HPV vaccines is experiencing similar events. This is a global problem. Vaccines are a medical intervention utilized in healthy populations. The precautionary principle must apply. It only makes good sense to temporarily suspend HPV vaccination programs until all safety and efficacy issues are resolved. Those individuals who are most susceptible to the risk of serious adverse events must be identified, quantified, qualified and eliminated from HPV vaccination programs. The current survivors of HPV vaccine injury must be identified, acknowledged and provided with appropriate medical treatment. Stop sacrificing children on the altar of The Greater Good Profit should never trump childrens health! Sources: Norma Erickson is the President of SaneVax, Inc., where this article first appeared. 